Sarfraz, M.; Afzal, A.; Yang, T.; Gai, Y.; Raza, S.M.; Khan, M.W.; Cheng, Y.; Ma, X.; Xiang, G.
Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies. Pharmaceutics 2018, 10, 151.
https://doi.org/10.3390/pharmaceutics10030151
AMA Style
Sarfraz M, Afzal A, Yang T, Gai Y, Raza SM, Khan MW, Cheng Y, Ma X, Xiang G.
Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies. Pharmaceutics. 2018; 10(3):151.
https://doi.org/10.3390/pharmaceutics10030151
Chicago/Turabian Style
Sarfraz, Muhammad, Attia Afzal, Tan Yang, Yongkang Gai, Shahid Masood Raza, Muhammad Waseem Khan, Yao Cheng, Xiang Ma, and Guangya Xiang.
2018. "Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies" Pharmaceutics 10, no. 3: 151.
https://doi.org/10.3390/pharmaceutics10030151
APA Style
Sarfraz, M., Afzal, A., Yang, T., Gai, Y., Raza, S. M., Khan, M. W., Cheng, Y., Ma, X., & Xiang, G.
(2018). Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies. Pharmaceutics, 10(3), 151.
https://doi.org/10.3390/pharmaceutics10030151